PCR

Circular Announces $10.5M in Funding to Scale First-of-its-Kind Platform for Sourcing Recycled Materials

Retrieved on: 
Monday, March 25, 2024

Circular.co , the leading sustainable sourcing platform, secured $10.5M to expand its massive database of post-consumer recycled (PCR) materials and its accompanying platform that streamlines buying and selling of PCR materials.

Key Points: 
  • Circular.co , the leading sustainable sourcing platform, secured $10.5M to expand its massive database of post-consumer recycled (PCR) materials and its accompanying platform that streamlines buying and selling of PCR materials.
  • Circular will use the funding to grow its team, expand to additional sustainable materials, continue to add more companies and suppliers, and deepen the scale and functionality of its platform.
  • Circular handles the searching, sourcing, vetting, and onboarding process for its customers, with results in days compared to months or even years, using analog methods.
  • “Buyers transitioning to recycled materials face the typical challenges of an emerging, analog market rife with inefficiency and a lack of transparency.

United States In-Vitro Diagnostics Market Analysis 2023-2030: Technological Advancements Drive IVD Adoption, Enhancing Patient Outcomes Fueling Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024

The market is poised for growth with the development of automatic IVD structures that provide improved efficiency, accuracy, and throughput.

Key Points: 
  • The market is poised for growth with the development of automatic IVD structures that provide improved efficiency, accuracy, and throughput.
  • This reflects a commitment to enhancing patient care through innovative technology and positioning the United States at the forefront of the in-vitro diagnostics market.
  • Technological advancements are set to propel the United States in the in vitro diagnostics (IVD) market.
  • Instruments are predicted to be among the leading products in the United States in vitro diagnostics (IVD) market.

NEP Sweden Launches New Remote Operation Centres, Bringing Connected Broadcast Production Solutions to Region

Retrieved on: 
Thursday, March 21, 2024

NEP Sweden, part of NEP Group , the leading media technology partner for content creators worldwide, today announced the successful launch of its new Remote Operation Centres (ROC) meeting the demand for connected broadcast production solutions in the region.

Key Points: 
  • NEP Sweden, part of NEP Group , the leading media technology partner for content creators worldwide, today announced the successful launch of its new Remote Operation Centres (ROC) meeting the demand for connected broadcast production solutions in the region.
  • View the full release here: https://www.businesswire.com/news/home/20240321734836/en/
    NEP Sweden's Remote Operation Centre (ROC) in Stockholm features five medium-sized production control rooms (PCR) and one large PCR.
  • The powerful broadcast control and networking solution empowers production teams by making IP 2110 technology fast and intuitive.
  • “There is a growing demand for connected production solutions, and we’re responding to the needs of our broadcast partners in the region by bringing the new NEP Sweden Remote Operation Centres online, applying NEP’s deep understanding and expertise of SMPTE IP 2110 infrastructure and making this innovative and environmentally sustainable solution available to our clients,” said Per de Navarro, Chief Technology Officer, NEP Sweden.

OTC/DTC Infectious Disease Diagnostics Market Strategies and Trends Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 21, 2024

The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country.

Key Points: 
  • The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country.
  • With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis."
  • Over the Counter and Direct to Consumer diagnostics are set to help solve the pandemic problem.
  • Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.

LiveWire® Announces All-New S2 Mulholland™ Electric Performance Cruiser

Retrieved on: 
Thursday, March 21, 2024

As LiveWire’s performance cruiser, S2 Mulholland's design departs from traditional internal combustion motorcycles in the cruiser category—which typically celebrate the gas tank—as the electric S2 platform provided the design team with the opportunity to create a new profile and experience that prominently displays both the brake lines and wiring harness, creating a stronger connection between the human interface of the rider and motorcycle.

Key Points: 
  • As LiveWire’s performance cruiser, S2 Mulholland's design departs from traditional internal combustion motorcycles in the cruiser category—which typically celebrate the gas tank—as the electric S2 platform provided the design team with the opportunity to create a new profile and experience that prominently displays both the brake lines and wiring harness, creating a stronger connection between the human interface of the rider and motorcycle.
  • S2 Mulholland is based on LiveWire’s S2 platform, and the riding characteristics of the motorcycle demonstrate the same level of performance established with S2 Del Mar.
  • While S2 Mulholland utilizes the same S2 platform, the riding experience has been reshaped by the rider triangle and updated standard equipment which diverges dramatically from Del Mar.
  • The introduction of the new electric performance cruiser, S2 Mulholland, will be limited to the U.S. and Canada for 2024, with deliveries for additional markets currently planned for 2025.

Global Immune Thrombocytopenia Drug Market Report 2024 with Analysts' Recommendations - Collaboration Initiatives with Healthcare Providers and Amplify Development of IV Drugs for Chronic Applications - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 12, 2024

The Global Immune Thrombocytopenia Drug market showcased growth at a CAGR of 21.32% during 2019-2022.

Key Points: 
  • The Global Immune Thrombocytopenia Drug market showcased growth at a CAGR of 21.32% during 2019-2022.
  • Immune Thrombocytopenia Drug Market is being propelled by rising prevalence of immune thrombocytopenia worldwide is a significant driver of the ITP drug market.
  • Technological advancements drive innovation and progress in the global Immune Thrombocytopenia Drug Market, accelerating drug discovery, development, manufacturing, and clinical practice.
  • The report analyses the Immune Thrombocytopenia Drug Market by End-User (Hospitals and Clinics, Specialty Centers, Research and Academic Institutes).

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Retrieved on: 
Thursday, April 4, 2024

Mr. Abbott holds a Master of Science degree from Brigham Young University and an M.B.A from the Wharton Business School.

Key Points: 
  • Mr. Abbott holds a Master of Science degree from Brigham Young University and an M.B.A from the Wharton Business School.
  • In his new role, Mr. Abbott will play a key role in the development and commercialization of the Co-Dx PCR platform and associated tests.
  • We welcome them in their new roles as the world continues its shift towards a more decentralized approach to diagnostics.
  • The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.

Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Controls to Ensure Consistent Quality and Optimal Performance of TCR and BCR Profiling Assays

Retrieved on: 
Thursday, April 4, 2024

MOUNTAIN VIEW, Calif., April 4, 2024 /PRNewswire/ -- Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Premixed Controls, the first commercially available collection of synthetic mRNA constructs that can serve as universal controls for commercial or home-brewed AIR repertoire sequencing (AIR-Seq, TCR-seq and BCR-seq) assays based on multiplex RT-PCR or 5' RACE PCR techniques.

Key Points: 
  • The first-to-market DriverMap™ AIR RNA TCR/BCR spike-in calibration controls measure the accuracy, sensitivity, and linear range of sequencing-based immune repertoire profiling assays.
  • The DriverMap™ AIR RNA Spike-In Controls' key characteristics include:
    These controls consist of 48 B-Cell Receptor (BCR) and 39 T-Cell Receptor (TCR) synthetic mRNA constructs designed to mimic all the different and most abundant TCR and BCR genes.
  • These standards and controls will help attain the goal of more reliable and reproducible AIR sequencing (AIR-Seq) data harmonization, interpretation, and sharing.
  • For more information on the DriveMap AIR RNA Spike-In Controls, including introductory pricing, visit www.cellecta.com/DriverMapAIR or email [email protected] .

John Paul Mitchell Systems® Announces Total Restage of Tea Tree Brand

Retrieved on: 
Wednesday, April 3, 2024

LOS ANGELES, April 3, 2024 /PRNewswire/ -- John Paul Mitchell Systems (JPMS™), a leading manufacturer of professional haircare products for the last 44 years, is continuing efforts to become an industry leader in regenerating natural resources and communities through people and plant-positive business practices. The Tea Tree brand, an aromatic line of botanical-inspired hair and body care products featuring Australian tea tree, has new elevated branding, updated imagery, and packaging from post-consumer recycled (PCR) plastic. Tea Tree bottles and jars are now made with 100% PCR, and tubes made with 25% PCR.** Additional packaging design features include new labels designed not to be removed before recycling, and the shampoo and conditioner bottles feature a raised S and C differentiator to increase accessibility.

Key Points: 
  • The Tea Tree brand, an aromatic line of botanical-inspired hair and body care products featuring Australian tea tree, has new elevated branding, updated imagery, and packaging from post-consumer recycled (PCR) plastic.
  • Tea Tree bottles and jars are now made with 100% PCR, and tubes made with 25% PCR.
  • The newly refreshed packaging launches with the best-selling Tea Tree Special line, with one shampoo and conditioner sold every 14 and 39 seconds***, respectively.
  • Tea Tree Special is also now available in reusable aluminum bottles—the ideal complement to the refill pouches which are made with 75% less plastic.

Prinics launches a new 'KODAK ERA' product line up

Retrieved on: 
Saturday, March 30, 2024

SEOUL, South Korea, March 30, 2024 /PRNewswire/ -- Prinics, a Korean-based printing technology company specializing in photo printers, launched its 'ERA' line with 6 products - Kodak MiniShot 4 ERA, Kodak MiniShot 3 ERA, Kodak MiniShot 2 ERA, Kodak Mini 3 ERA, Kodak Mini 2 ERA, and Kodak Dock ERA in the USA on March 15, 2024.

Key Points: 
  • SEOUL, South Korea, March 30, 2024 /PRNewswire/ -- Prinics, a Korean-based printing technology company specializing in photo printers, launched its 'ERA' line with 6 products - Kodak MiniShot 4 ERA, Kodak MiniShot 3 ERA, Kodak MiniShot 2 ERA, Kodak Mini 3 ERA, Kodak Mini 2 ERA, and Kodak Dock ERA in the USA on March 15, 2024.
  • The ERA products offer state-of-the-art features for high-quality photos and allow you to print memorable moments.
  • The KODAK ERA line draws inspiration from the motif of a 35mm film, incorporating Kodak's 135-year heritage and featuring the iconic black and yellow, Kodak's brand colors.
  • This product line makes use of cartridges made from 100% PCR recycled plastic and uses eco-friendly paper packaging which generally consumes less energy compared to manufacturing of plastic packaging.